MST3

MST3 (STK24) is a serine/threonine kinase in the germinal-center kinase III family, with an N-terminal kinase domain and C-terminal regulatory domain[1]. Mechanistically, caspase cleavage activates MST3 kinase activity, promotes nuclear translocation, and induces apoptotic morphology in Jurkat-cell apoptosis models[2]. MST3 also phosphorylates NDR1/2 at hydrophobic-motif sites and supports G1/S cell-cycle progression through the NDR-p21 axis[3][4]. In neural models, MST3 phosphorylates TAO1/2 to enable Myosin Va-dependent dendritic localization and excitatory synapse development[5]. Cdk5-dependent MST3 phosphorylation regulates neuronal migration by inhibiting RhoA activity[6]. In immune-cell models, the CCM3-STK24 complex coordinates UNC13D-driven vesicle exocytosis in neutrophils[7]. Compared with related isoforms, MST3/STK24 differs from MST1/2 in experimental inhibitor response, because MST3/4-selective inhibition causes G1 arrest, whereas MST1/2 inhibition causes G2/M accumulation[8]. For experimental applications, MR24 and MR30 provide selective MST3/4 chemical tools for dissecting MST3-dependent cell-cycle biology[8].- MST3 connects apoptosis, cell-cycle control, neuronal migration, synapse development, and neutrophil exocytosis.- MST3 differs from MST1/2 through distinct inhibitor-driven cell-cycle arrest phenotypes.- MST3/4 inhibitors support pathway dissection, but disease-translation claims require model-specific validation.
Verweise: